Ask a question. Get a source-grounded answer with citations.
Based on 10 verified sources covering Thailand:
TOKYO -- French eyewear group EssilorLuxottica, owner of the well-known Ray-Ban brand, has increased its stake in Japan's Nikon to 10.59%, according to a disclosure filed in Japan on Monday. (confirmed by 2 sources) [1]
TOKYO -- U.S. pharmaceutical giant Bristol Myers Squibb will produce advanced cancer immunotherapies in Japan, partnering with a Nikon pharmaceutical subsidiary to manufacture treatments that make use of the body's immune cells. [2]
PharmaceuticalsJapan's Nikon, others to invest $675m in cutting-edge drug production Companies look to tap rising demand for regenerative medicines Nikon and other companies produce advanced therapies, some using stem cells, on a contract basis. [3]
TOKYO -- Faced with mounting headwinds in digital cameras, Nikon has launched a 100 billion yen ($620 million) investment spree to redirect expertise in optical products to promising sectors like space and semiconductors. [4]
TOKYO -- Nikon plans to breathe new life into its lackluster chipmaking equipment business by selling a new product in China that uses technology old enough not to be subject to export controls. [5]
TOKYO -- Nikon said Friday it has agreed to take over German 3D printer maker SLM Solutions Group in a deal that will ultimately be worth 622 million euros ($621 million). [6]
TOKYO -- Upon its launch in 1959, Nikon declared the Nikon F the "ultimate" single-lens reflex camera, able to "meet all photography needs in a single device." TechnologyNikon closes book on six decades of SLR camera history Nikon F and digital succe... [7]
TOKYO -- Nikon officially announced on Oct. 30 plans to close a digital camera plant in Wuxi, China as part of its structural reform program running through fiscal 2018, which prioritizes profitability over expansion. [8]
TOKYO -- French eyewear group EssilorLuxottica, owner of the well-known Ray-Ban brand, has increased its stake in Japan's Nikon to 10.59%, according to a disclosure filed in Japan on Monday.
TOKYO -- U.S. pharmaceutical giant Bristol Myers Squibb will produce advanced cancer immunotherapies in Japan, partnering with a Nikon pharmaceutical subsidiary to manufacture treatments that make use of the body's immune cells.
PharmaceuticalsJapan's Nikon, others to invest $675m in cutting-edge drug production Companies look to tap rising demand for regenerative medicines Nikon and other companies produce advanced therapies, some using stem cells, on a contract basis.
TOKYO -- Faced with mounting headwinds in digital cameras, Nikon has launched a 100 billion yen ($620 million) investment spree to redirect expertise in optical products to promising sectors like space and semiconductors.
TOKYO -- Nikon plans to breathe new life into its lackluster chipmaking equipment business by selling a new product in China that uses technology old enough not to be subject to export controls.
TOKYO -- Nikon said Friday it has agreed to take over German 3D printer maker SLM Solutions Group in a deal that will ultimately be worth 622 million euros ($621 million).
TOKYO -- Upon its launch in 1959, Nikon declared the Nikon F the "ultimate" single-lens reflex camera, able to "meet all photography needs in a single device." TechnologyNikon closes book on six decades of SLR camera history Nikon F and digital succe
TOKYO -- Nikon officially announced on Oct. 30 plans to close a digital camera plant in Wuxi, China as part of its structural reform program running through fiscal 2018, which prioritizes profitability over expansion.
TOKYO -- Nikon's operating profit for the April-September half apparently shrank about 30% on the year, but beat projections of a 37% plunge thanks to improved sales of digital cameras and restructuring.
TOKYO -- Nikon is re-entering the mirrorless camera market after ceasing production in 2017, and plans to launch a luxury model with a high-performance sensor by year-end.